Montclair, NJ, United States of America

Arthur R Mlodozeniec


Average Co-Inventor Count = 1.7

ph-index = 8

Forward Citations = 424(Granted Patents)


Company Filing History:


Years Active: 1977-1982

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Arthur R. Mlodozeniec: Innovator in Pharmaceutical Dosage Forms

Introduction

Arthur R. Mlodozeniec is a notable inventor based in Montclair, NJ (US), recognized for his contributions to the field of pharmaceutical dosage forms. He holds a total of 9 patents, showcasing his innovative approach to medication delivery systems.

Latest Patents

Among his latest patents, Mlodozeniec has developed novel dosage forms that comprise an edible web with a particulate medicament deposited thereon. These dosage forms are fabricated to ensure that no medicament is exposed on the exterior surface, allowing for a controlled release of the medicament to exacting specifications. The manufacturing process utilizes high-speed automated equipment, characterized by non-destructive quality control analysis and performance evaluation conducted online. This innovative approach also includes certain apparatus and methods of manufacture that enhance the efficiency and effectiveness of pharmaceutical production.

Career Highlights

Arthur R. Mlodozeniec is currently associated with Hoffmann-La Roche Inc., where he continues to advance the field of pharmaceutical sciences. His work has significantly impacted the way medications are formulated and delivered, ensuring that patients receive effective treatments in a reliable manner.

Collaborations

Throughout his career, Mlodozeniec has collaborated with esteemed colleagues, including Arthur H. Goldberg and August Sturzenegger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

Arthur R. Mlodozeniec's contributions to pharmaceutical dosage forms exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving medication delivery systems, ultimately benefiting patients and the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…